MBMerve Boyraz

Merve Boyraz

*This is an algorithmically generated author record based on publicly available information.

Merve Boyraz has a total of 76 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Subclavian central venous catheterization in critically ill children in Türkiye: a safe and feasible approach in a single-center experience

    by Abdulrahman Özel, Esma Nur Özen, Servet Yüce, Sude Menekşe, Hazal Erdem, Merve Boyraz

    Background: Central venous catheterization (CVC) is an essential procedure in the management of critically ill pediatric patients. However, the optimal catheter insertion site remains controversial due to varying complication rates. This study aimed to evaluate the feasibility and safety of subclavian vein (SCV) catheterization compared to femoral vein (FV) and internal jugular vein (IJV) access in a pediatric intensive care setting.Methods: This retrospective study included all patients admitted to the pediatric intensive care unit (PICU) of a tertiary hospital over a one-year period (March 2022–March 2023) who underwent nontunneled central venous catheter placement.Results: Among 174 patients included (median age 29 months, 60.3% male), 52.9% had SCV, 23.6% FV, and 23.6% IJV catheterization. The overall CVC success rate was 99.4%. There was no statistically significant difference in mechanical complications, catheter-related bloodstream infections, or thrombosis between groups, however, thrombosis occurred most frequently in the FV group (12.2%). The median age in the SCV group was significantly lower than in the other groups (20 months; interquartile range, 10–63; P<0.001), while the presence of chronic diseases was significantly higher in this group (P=0.02). In multivariate logistic regression, catheter site was identified as the only independent predictor of thrombosis, with FV catheterization associated with increased risk (OR, 2.75; P=0.016).Conclusions: SCV catheterization appears to be a feasible and safe option for critically ill children, even in younger patients and in the presence of chronic comorbidities. Despite potential technical challenges, SCV access represents a viable alternative to IJV and may offer potential advantages over FV, particularly with regard to thrombosis risk.

  • Open Access

    Impact of Immunotherapy Combinations on Clinical Outcomes in Children with Acute Flaccid Paralysis: A Multicenter Intensive Care Study

    by Edin Botan, Merve Boyraz, Servet Yüce, Hazal Ceren Tuğrul, Emrah Gün, Şeyma Erdem Torun, Hasan Özen, Merve Havan, Ayşe Aşık, Anar Gurbanov, et al.

    Objective: Acute flaccid paralysis (AFP) is a syndrome characterized by the rapid onset of limb weakness and decreased muscle tone, frequently accompanied by respiratory or bulbar involvement. Methods: This retrospective multicenter study evaluated the clinical characteristics, treatment modalities, intensive care processes, and outcomes of 68 children diagnosed with AFP who were admitted to pediatric intensive care units (PICUs) between January 1, 2018, and January 1, 2023. Results: The patients’ ages ranged from 1 month to 18 years (mean 7.9 ± 4.5 years), and 33 (48.5%) were male. The mean PICU stay was 15.4 ± 19.5 days, and the mean total hospital stay was 23.3 ± 21.1 days. Respiratory support was required in 42 patients (61.8%). All patients received intravenous immunoglobulin (IVIG). Therapeutic plasma exchange (TPE) was administered to 25 of 43 Guillain–Barré syndrome (GBS) patients, 7 of 11 transverse myelitis (TM) patients, and 11 of 14 acute disseminated encephalomyelitis (ADEM) patients. Among 14 intubated GBS patients, 5 received IVIG for ≤2 days and 9 for ≥4 days. The duration of invasive mechanical ventilation (MV) was significantly longer in patients receiving IVIG for ≥4 days (P=.044). Guillain–Barré syndrome patients treated with combined IVIG and TPE had longer PICU stays compared with those receiving IVIG alone (P=.001). Conclusion: Combination immunotherapies were associated with longer MV duration and PICU stay compared with monotherapy in AFP patients. In intubated GBS patients, administration of IVIG over 2 days was associated with a shorter duration of invasive MV.

  • Open Access

    Multiple organ dysfunction syndrome in pediatric colchicine poisoning: a national cohort study from Türkiye

    by Faruk Eki̇nCi̇, Di̇nÇer Yildizdaş, Ozden Özgür Horoz, Hayri̇ Levent Yilmaz, Sevcan Bi̇lEn, İlKer Ünal, İkBal Türker, Esra Şevketoğlu, Ni̇hAl Akçay, Agop Çitak, et al.

    Background/aim: Colchicine poisoning has been associated with systemic toxicity, multiple organ dysfunction syndrome (MODS), and mortality. In the present study, the demographic, clinical, and laboratory characteristics of pediatric colchicine poisoning cases and the incidence of organ failure are investigated to identify potential risk factors associated with MODS. Materials and methods: Included in this retrospective multicenter cohort study were pediatric patients admitted to 28 tertiary-care pediatric intensive care units with a diagnosis of colchicine poisoning. Demographic data, clinical and laboratory findings, and clinical outcomes were extracted from medical records. MODS was defined as dysfunction involving at least two organ systems. Multivariable logistic regression analysis was performed to identify the variables independently associated with MODS. Results: Of the 150 patients included in the study, 40% were younger than 5 years and 52% were older than 13 years. Gastrointestinal symptoms were most prominent, with nausea and vomiting observed in 64.7%, abdominal pain in 36.7%, and diarrhea in 24%. Overall, 66% developed no organ failure, while single-organ failure occurred in 7.3% and 26.7% developed MODS. The coagulation system was most frequently affected (26%), followed by the hematological (19.3%) and immunological (18%) systems. Multivariable logistic regression analysis identified the baseline PRISM III score, ingested colchicine dose per kilogram of body weight, and initial sodium, creatinine, and aspartate aminotransferase (AST) levels as independent predictors of MODS. Conclusion: MODS can develop at ingestion doses lower than 0.5 mg/kg, which have historically been considered safe. Higher ingested doses and elevated PRISM III scores were associated with MODS, although these findings are derived from retrospective observational data and should not be interpreted as causal or as direct clinical recommendations. Further prospective studies are needed to clarify relevant doses, interventions, and prognostic factors in pediatric colchicine poisoning associated with MODS.

  • Open Access

    Early surgical intervention in pediatric trauma patients with GCS 3 – Results of 8 Years experience

    by Merve Boyraz, Servet Yüce, Abdulrahman Özel, Mehmet Tolgahan Örmeci, Hasan Özen, Süleyman Akkaya, Edin Botan


  • Open Access

    Neurological Complications in MIS-C: Case Report

    by Edin Botan, Metin Ay, Merve Boyraz, Derya Bako, Servet Yüce

    COVID-19 has ser ously a ected ch ldren and the whole world. Ped atr c mult-system nflammatory syndrome (MIS-C), a new syndrome that has not been known before, has been descr bed. Although MIS-C may progress w th d erent cl n cal man festat ons n ch ldren, neurolog cal nvolvement s reported relat vely rarely. A 12-year-old g rl w th cerebral palsy and motor mental retardat on was adm tted to the emergency department w th compla nts of cough, fever, mouth sores and malnutr t on. As a result of the evaluat on, the pat ent was hosp tal zed to nvest gate the et ology of the fever and emp r cal ant b ot c treatment was started, and she developed a rash on the 3rd day and ton c-clon c convuls ons on the 5th day. The pat ent was hosp tal zed n the ped atr c ntens ve care un t (PICU), and COVID-19 IgG and IgM were pos t ve. Cerebral mag ng of the pat ent was reported as normal. The pat ent w th fever, rash, convuls ons last ng longer than f ve days, and compat ble laboratory results were d agnosed w th MIS-C. Intravenous mmunoglobul n (IVIG) and methylpredn solone treatments were started, and the pat ent was d scharged on the 14th day of hosp tal zat on, whose cond t on mproved. Th s case s presented as an example of the rare neurolog cal nvolvement of MIS-C. Deta led cl n cal nvest gat on and neurolog cal exam nat on are requ red to exclude neurolog cal sequelae of COVID-19 dur ng the pandem c. The development of general gu del nes that can comb ne them would be nstruct ve.

  • Pseudo-Outbreaks of Stenotrophomonas maltophilia on a Pediatric Intensive Care Unit in Türkiye

    by Edin Botan, Merve Boyraz, Emine Ulu Botan, Feride Akış, Servet Yüce, Zerrin Epçaçan


  • Pseudo-Outbreaks of Stenotrophomonas maltophilia on a Pediatric Intensive Care Unit in Türkiye

    by Edin Botan, Merve Boyraz, Emine Ulu Botan, Feride Akış, Servet Yüce, Zerrin Epçaçan

  • Descriptive and Clinical Characteristics of Nonsurvivors in a Tertiary Pediatric Intensive Care Unit in Turkey: 6 Years of Experience

    by Zeynep Karakaya, Merve Boyraz, Seyma Koksal Atis, Servet Yuce, Muhterem Duyu

    The objective of this study was to identify the characteristics of nonsurvivors in a pediatric intensive care unit (PICU) in Turkey. This is a retrospective analysis of patients who died in a tertiary PICU over a 6-year period from 2016 to 2021. Data were drawn from electronic medical records and resuscitation notes. Mode of death was categorized as failed cardiopulmonary resuscitation (F-CPR) or brain death. Among the 161 deaths, 136 nonsurvivors were included and 30.1% were younger than 1 year. Severe pneumonia, respiratory failure, and acute respiratory distress syndrome (ARDS) (31.6%) were the most common primary diagnoses. The most common mode of death was F-CPR (86.8%). More than half of the subjects had been admitted from pediatric emergency departments (58.1%), and more than half (53.7%) had died within 7 days in the PICU. Patients admitted from pediatric emergency departments had the lowest frequency of comorbidities (p < 0.001). Severe pneumonia, respiratory failure, and ARDS diagnoses were significantly more frequent in those who died after 7 days (p < 0.001), whereas septicemia, shock, and multiple organ dysfunction were more common among those who died within the first day of PICU admission (p < 0.001). It may be important to note that patients referred from wards are highly likely to have comorbidities, while those referred from pediatric emergency departments may be relatively younger. Additionally, patients with septicemia, shock, or multiple organ dysfunction were more likely to die earlier (within 7 days), especially compared with those with severe pneumonia, respiratory failure, or ARDS.